The online version of this article (doi:10.1186/1475-2840-11-17) contains supplementary material, which is available to authorized users.
This article was supported by research grants from the Scientific Research Fund of Liaoning Science and Technology Agency, China (No. 2008225010-5) and the Scientific Research Fund of Liaoning Education Agency, China (No. 2007T183) and the Scientific Research Fund of First Hospital of CMU (No. FSFH1006).
The authors have not signed an agreement with any sponsor of the study reported in this article that has a clause which prevents us from publishing both positive and negative results, from collaborating with other investigators to pool data across sites, or that forbids us from publishing without the approval of the sponsor.
The authors declare that they have no competing interests.
LX conceived of the study, and participated in its design and coordination, carried out the clinical studies and helped to draft the manuscript. D-sH participated in the design of the study and performed the statistical analysis. J-jT carried out the clinical studies and drafted the manuscript. JS carried out the clinical studies and drafted the manuscript. All authors read and approved the final manuscript.
The purpose of this study was to assess the efficacy of interventional therapy for peripheral arterial occlusive disease and the difference between diabetic patients and non-diabetic patients.
139 consecutive patients between September 2006 and September 2010 who underwent percutaneous lower extremity revascularization for arterial lesions were divided into diabetes group (n = 62) and non-diabetes group (n = 77). Before intervention, rest ankle brachial indexes and three dimensional computed tomography angiography from abdominal aorta to tiptoe were performed. The interventional treatments included angioplasty with or without stenting. The clinical outcomes included rest ankle-brachial indexes, primary patency rates, secondary patency rates and limb-salvage rates for 6-month, 12-month, 24-month and 36-month after treatment. The primary and secondary patency rates of all interventions and the limb-salvage rates of the patients are illustrated by Kaplan-Meier curves and compared by log-rank analysis.
The interventional operation success rates were 98.4% (61/62) in diabetes group and 100% (77/77) in non-diabetes group. The re-interventional operation success rates were 85.7% (18/21) in diabetes group and 76.9% (20/26) in non-diabetes group. The mean value of ankle brachial indexes was significantly increased after intervention (0.397 ± 0.125 versus 0.779 ± 0.137, t = -25.780, P < 0.001) in diabetes group and (0.406 ± 0.101 versus 0.786 ± 0.121, t = -37.221, P < 0.001) in non-diabetes group. Perioperative 30-day mortality was 0%. Major complications included groin hematoma in 7.2%, and pseudoaneurysm formation 2.2%. In diabetes group, 6, 12, 24, and 36-month primary patency rates were 88.7% ± 4.0%, 62.3% ± 6.6%, 55.3% ± 7.0%, and 46.5% ± 7.5%; secondary patency rates were 93.5% ± 3.1%, 82.3% ± 5.1%, 70.8% ± 6.5%, and 65.7% ± 7%; limb-salvage rates were 95.2% ± 2.7%, 87.7% ± 4.4%, 85.5% ± 4.8%, and 81.9% ± 5.8%. In non-diabetes group, 6, 12, 24, and 36-month primary patency rates were 90.9% ± 3.3%, 71.8% ± 5.4%, 71.8% ± 5.4%, and 60.9% ± 6.2%; secondary patency rates were 96.1% ± 2.2%, 91.6% ± 3.3%, 82.7% ± 4.8%, and 71.8% ± 6.2%; limb-salvage rates were 97.4% ± 1.8%, 94.4% ± 2.7%, 90.6% ± 3.7%, and 83.1% ± 5.4%. The differences between two groups were not significant (P > 0.05).
With a low risk of morbidity and mortality, the percutaneous revascularization accepted by patients does not affect ultimate necessary surgical revascularization and consequently should be considered as the preferred therapy for chronic lower extremity ischemia. The efficacy and prognosis of interventional therapy in diabetic patients is similar that in non-diabetic patients.
Authors’ original file for figure 112933_2012_440_MOESM1_ESM.tiff
Authors’ original file for figure 212933_2012_440_MOESM2_ESM.tiff
Authors’ original file for figure 312933_2012_440_MOESM3_ESM.tiff
Authors’ original file for figure 412933_2012_440_MOESM4_ESM.pdf
Authors’ original file for figure 512933_2012_440_MOESM5_ESM.pdf
Authors’ original file for figure 612933_2012_440_MOESM6_ESM.pdf
Authors’ original file for figure 712933_2012_440_MOESM7_ESM.tiff
Authors’ original file for figure 812933_2012_440_MOESM8_ESM.tiff
Authors’ original file for figure 912933_2012_440_MOESM9_ESM.tiff
Authors’ original file for figure 1012933_2012_440_MOESM10_ESM.tiff
Authors’ original file for figure 1112933_2012_440_MOESM11_ESM.tiff
Authors’ original file for figure 1212933_2012_440_MOESM12_ESM.tiff
Authors’ original file for figure 1312933_2012_440_MOESM13_ESM.tiff
Authors’ original file for figure 1412933_2012_440_MOESM14_ESM.tiff
Authors’ original file for figure 1512933_2012_440_MOESM15_ESM.tiff
Authors’ original file for figure 1612933_2012_440_MOESM16_ESM.tiff
Authors’ original file for figure 1712933_2012_440_MOESM17_ESM.tiff
Authors’ original file for figure 1812933_2012_440_MOESM18_ESM.tiff
Authors’ original file for figure 1912933_2012_440_MOESM19_ESM.tiff
Eschwege E, Simon D, Balkau B: The growing burden of diabetes in the world population. International Diabetes Federation Bulletin. 1997, 42: 14-19.
Micari A, Vadalà G, Biamino G: Update on the TURBO BOOSTER spectranetics laser for lower extremity occlusive disease. J Cardiovasc Surg (Torino). 2010, 51: 233-243.
Bosiers M, Peeters P, D'Archambeau O, Hendriks J, Pilger E, Düber C, Zeller T, Gussmann A, Lohle PN, Minar E, Scheinert D, Hausegger K, Schulte KL, Verbist J, Deloose K, Lammer J: AMS INSIGHT Investigators. AMS INSIGHT-absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol. 2009, 32: 424-435. 10.1007/s00270-008-9472-8. PubMedCentralCrossRefPubMed
Jahnke T, Mueller-Huelsbeck S, Charalambous N, Trentmann J, Jamili A, Huemme TH, Bolte H, Heller M, Schaefer PJ: Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study. J Vasc Interv Radiol. 2010, 21: 186-194. 10.1016/j.jvir.2009.10.021. CrossRefPubMed
Zeller T, Krankenberg H, Steinkamp H, Rastan A, Sixt S, Schmidt A, Sievert H, Minar E, Bosiers M, Peeters P, Balzer JO, Gray W, Tübler T, Wissgott C, Schwarzwälder U, Scheinert D: One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther. 2009, 16: 653-662. 10.1583/09-2826.1. CrossRefPubMed
Tuttolomondo A, La Placa S, Di Raimondo D, Bellia C, Caruso A, Lo Sasso B, Guercio G, Diana G, Ciaccio M, Licata G, Pinto A: Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol. 2010, 9: 50-10.1186/1475-2840-9-50. PubMedCentralCrossRefPubMed
Ho DY, Cook NR, Britton KA, Kim E, Creager MA, Ridker PM, Pradhan AD: High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation. Circulation. 2011, 124: 2303-2311. 10.1161/CIRCULATIONAHA.111.045187. PubMedCentralCrossRefPubMed
Poulsen MK, Nybo M, Dahl J, Hosbond S, Poulsen TS, Johansen A, Høilund-Carlsen PF, Beck-Nielsen H, Rasmussen LM, Henriksen JE: Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. Cardiovasc Diabetol. 2011, 10: 76-10.1186/1475-2840-10-76. PubMedCentralCrossRefPubMed
Hall KV: The great saphenous vein used in-situ as an arterial shunt after extirpation of vein valves. Surgery. 1962, 51: 492-499. PubMed
Hanna GP, Fujise K, Kjellgren O, Feld S, Fife C, Schroth G, Clanton T, Anderson V, Smalling RW: Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry. J Am Coll Cardiol. 1997, 30: 664-669. 10.1016/S0735-1097(97)00216-7. CrossRefPubMed
Park KB, Do YS, Kim DI, Kim DK, Kim YW, Shin SW, Cho SK, Choo SW, Choe YH, Choo IW: The transatlantic intersociety consensus (TASC) classification system in iliac arterial stent placement: long-term patency and clinical limitations. J Vasc Interv Radiol. 2007, 18: 193-201. 10.1016/j.jvir.2006.12.726. CrossRefPubMed
Lejay A, Georg Y, Bajcz C, Thaveau F, Geny B, Kretz JG, Chakfé N: Endovascular treatment of infra-popliteal arteries in patients with critical limb ischemia. Acta Chir Belg. 2009, 109: 684-693. PubMed
- Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II